TDRD9

TDRD9 is a DExH-type RNA helicase that functions as an essential effector of the piRNA pathway in the mammalian germline, coupling piRNA-guided transposon recognition to epigenetic silencing. In fetal male gonocytes, TDRD9 physically complexes with the PIWI protein MIWI2 in piP-body cytoplasmic granules, where it is required for LINE-1 retrotransposon silencing and de novo DNA methylation at transposon loci; its ATPase catalytic activity is dispensable for piRNA biogenesis itself but essential for transposon repression and male fertility (PMID:20059948, PMID:28633017). Assembly of the TDRD9–MIWI2 module in piP-bodies depends on upstream factors MAEL and MILI/TDRD1 operating at intermitochondrial cement, establishing a hierarchical granule organization in the piRNA pathway (PMID:20011505, PMID:20059948). Loss of Tdrd9 in mice causes meiotic failure, spermatogenic arrest, and male sterility accompanied by massive LINE-1 derepression (PMID:20059948).

1. 2009 High

   Establishing that TDRD9 is a piRNA pathway component: its physical interaction with MIWI2 in piP-bodies, requirement for LINE-1 silencing and de novo DNA methylation, and essential role in male fertility answered the question of what TDRD9 does in the germline.

   Evidence Co-IP, immunofluorescence, Tdrd9-knockout mice with LINE-1 expression, DNA methylation, and piRNA profiling in mouse gonocytes

   PMID:20059948

   Open questions at the time

   • Whether TDRD9 helicase activity itself is catalytically required versus serving a scaffolding role
   • Direct RNA substrates of TDRD9 remain unidentified
   • Mechanism by which TDRD9 promotes de novo DNA methylation not resolved
2. 2009 High

   Defining the granule hierarchy of the piRNA pathway: TDRD9–MIWI2 occupy piP-bodies distinct from MILI–TDRD1-containing pi-bodies, and MAEL is required for piP-body integrity, revealing that piRNA pathway components are organized into functionally distinct cytoplasmic compartments.

   Evidence Immunofluorescence co-localization combined with genetic epistasis using Mael-knockout and Tdrd9-knockout mice, piRNA sequencing

   PMID:20011505 PMID:20059948

   Open questions at the time

   • How MAEL recruits or stabilizes TDRD9–MIWI2 at piP-bodies is unknown
   • Whether piP-body localization is required for TDRD9 function or merely correlative
3. 2011 High

   Clarifying pathway specificity: TDRD9 operates in a piRNA-dependent LINE-1 suppression pathway distinct from the piRNA-independent mechanism used by TDRD7, indicating non-redundant transposon control branches within the TDRD family.

   Evidence Genetic epistasis using Tdrd7/Tdrd6 single and double knockouts with LINE-1 expression assays

   PMID:21670278

   Open questions at the time

   • Molecular basis for why TDRD9 requires piRNA biogenesis while TDRD7 does not
   • Whether TDRD9 and TDRD7 suppress distinct transposon families
4. 2013 Medium

   Extending TDRD9's expression beyond the male germline: its localization to nuage-like structures in oocytes of primordial follicles together with MVH and MILI raised the possibility of a conserved female piRNA pathway role.

   Evidence Immunofluorescence in mouse ovarian tissue

   PMID:23924633

   Open questions at the time

   • No functional data for TDRD9 in the female germline (localization only)
   • Whether TDRD9 loss affects oocyte development or female fertility not tested
5. 2017 High

   Dissecting catalytic versus structural roles: ATPase-dead TDRD9 knock-in mice retain normal piRNA biogenesis but fail to silence transposons and are male-sterile, establishing that TDRD9 ATPase activity acts downstream of piRNA production at the effector step of transposon silencing.

   Evidence ATPase-dead point mutant knock-in mice with piRNA sequencing, transposon expression assays, and fertility testing

   PMID:28633017

   Open questions at the time

   • The direct molecular substrate unwound or remodeled by TDRD9 ATPase activity is unknown
   • Whether TDRD9 acts on piRNA–target RNA duplexes, chromatin-associated RNAs, or other substrates
6. 2017 Medium

   Revealing a cancer-cell-autonomous role: TDRD9 is aberrantly expressed in NSCLC through promoter hypomethylation and its knockdown causes replication stress, DNA damage, and apoptosis, suggesting it supports genome stability in cells that ectopically express it.

   Evidence siRNA knockdown in NSCLC cell lines, flow cytometry, γH2A.X and DNA-PKcs Western blot, aphidicolin sensitivity assays

   PMID:29515758

   Open questions at the time

   • Mechanism linking TDRD9 to replication fork stability in somatic cells not established
   • Whether this reflects the canonical piRNA/helicase function or a moonlighting activity is unknown
   • Single lab, not independently replicated
7. 2019 Medium

   Refining the interactome within piP-bodies: in rat gonocytes, TDRD9 co-localizes with MAEL and PIWIL4 but does not physically interact with DAZL or MAEL by co-IP, indicating compartment co-residence does not equate to direct complex membership.

   Evidence Co-IP and immunofluorescence in rat embryonic gonads

   PMID:31181099

   Open questions at the time

   • The full set of direct binding partners of TDRD9 beyond MIWI2 remains undefined
   • Species differences (rat vs. mouse) in piP-body composition not systematically addressed
8. 2026 Medium

   Uncovering a non-germline function: in neutrophils, TDRD9 suppresses cuproptosis by interacting with CD80 to activate p38 MAPK and upregulate PD-L1, with in vivo relevance in bacterial pneumonia, revealing an unexpected immune-regulatory role.

   Evidence Co-IP for TDRD9–CD80 interaction, siRNA knockdown, p38/PD-L1 Western blot, adoptive transfer of TDRD9-silenced neutrophils in mouse pneumonia model

   PMID:41792170

   Open questions at the time

   • Not independently replicated; novel non-germline mechanism from a single study
   • How TDRD9, an RNA helicase, mechanistically activates p38 MAPK through CD80 binding is unclear
   • Whether this function depends on TDRD9 helicase activity not tested

• The direct RNA or ribonucleoprotein substrates of TDRD9 ATPase/helicase activity remain unidentified, and the molecular mechanism by which TDRD9 catalytic activity promotes transposon silencing and de novo DNA methylation downstream of piRNA loading is unresolved.
• No structural model of TDRD9 or its complex with MIWI2 exists
• Whether TDRD9 unwinds piRNA–target duplexes, remodels RNP complexes, or acts on chromatin-associated transcripts is unknown
• The link between TDRD9 ATPase activity and recruitment of the de novo DNA methylation machinery has not been delineated